Next, we used CD4+ T/CD8+ T/NK cell antibodies to antagonize the corresponding lymphocyte subsets before radiotherapy to evaluate the contribution of different immune cells to the anti-tumor effects of RT (Fig. 5A). Here, CD8A is linked to neoplasm.